Life Sciences

Full product development IVD CMO comprises companies that partner with OEMs and support them in the development of IVD devices, ranging from concept to commercialization. IVD companies are continuously looking at new ways to optimize resources due to rising cost pressures and regulatory complexities, prompting industry participants to adopt innovat...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...

The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...

13 Sep 2016  |  North America  |  Market Research

US Next-generation Sequencing Services Market

$1,000 Genome Pricing and Throughput to Drive More and Larger Sequencing Projects

Infographics

×

The next-generation sequencing (NGS) services market includes all sequencing services conducted with next-generation or third-generation platforms that use newer technology than traditional capillary electrophoresis (CE) sequencing. Services include project scoping, NGS sample preparation tasks (i.e., library prep and target enrichment), and NGS-ba...

25 Jul 2016  |  North America  |  Market Research

US Hospital Cybersecurity Market—2015–2021

Healthcare Gears Up to Combat the Growing Risk of Cyber Attacks

Infographics

×

The report describes and defines the market for various types of solutions (products and services) deployed by US hospitals to protect the security of enterprise information technology (IT) systems and the privacy and security of patient information; covers key factors driving the need to deploy these solutions in response to dynamic industry shift...

Frost & Sullivan reviews key themes and industry trends from the 5th Annual Digital Health Summer Summit and BIO International held in June 2016. Major topics covered include the use of virtual and augmented reality in medical education and clinical care; new digital health technologies to improve mental health; investor perspectives on the market ...

With regards to wearables and healthcare, strong customer demand and surging sales are only part of the story. The other side of the narrative captures the tale of a highly volatile marketplace where, due to intense competition, there is a revolving door of company entries and exits. Accordingly, Frost & Sullivan’s team, through its tracking of w...